Prelude Therapeutics Incorporated (PRLD)

NASDAQ: PRLD · IEX Real-Time Price · USD

3.720

+0.280 (8.14%)

At close: Apr 19, 2024, 4:00 PM

3.855

+0.135 (3.63%)

After-hours: Apr 19, 2024, 5:14 PM EDT

Prelude Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-121.83	-115.44	-111.69	-56.93	-27.57	-14.68
Depreciation & Amortization	3.11	3.04	2.24	0.54	0.38	0.15
Share-Based Compensation	25.62	25.14	20.93	5.58	0.85	0.18
Other Operating Activities	-13.95	3.52	4.99	4.63	0.68	1.4
Operating Cash Flow	-107.06	-83.73	-83.53	-46.18	-25.67	-12.95
Capital Expenditures	-3.51	-3.02	-2.32	-0.62	-0.78	-0.53
Change in Investments	-31.13	84.71	-261.48	0	0	0
Investing Cash Flow	-34.65	81.69	-263.8	-0.62	-0.78	-0.53
Share Issuance / Repurchase	136.41	0.82	165.2	166.73	0.01	0
Debt Issued / Paid	0	0	0	-0.26	-0.12	0
Other Financing Activities	-0.02	-	-0.3	79.76	29.85	17.94
Financing Cash Flow	136.4	0.82	164.9	246.23	29.73	17.94
Net Cash Flow	-5.31	-1.22	-182.44	199.43	3.28	4.45
Free Cash Flow	-110.58	-86.75	-85.85	-46.8	-26.45	-13.48
Free Cash Flow Per Share	-1.83	-1.83	-1.86	-3.75	-15.85	-8.31

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).